Previous close | 68.50 |
Open | 68.10 |
Bid | 67.50 x 1200 |
Ask | 67.84 x 800 |
Day's range | 67.48 - 68.21 |
52-week range | 64.41 - 83.25 |
Volume | |
Avg. volume | 9,455,201 |
Market cap | 85.423B |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | 10.47 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.66 (3.93%) |
Ex-dividend date | 19 Apr 2024 |
1y target est | N/A |
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
In the most recent trading session, CVS Health (CVS) closed at $69.75, indicating a +0.52% shift from the previous trading day.